Cargando…

Regulatory and Memory B Lymphocytes in Children With Newly Diagnosed Immune Thrombocytopenia

BACKGROUND: Immune (idiopathic) thrombocytopenic purpura (ITP) is a primary autoimmune disease. It is characterized by a diminished peripheral platelet count (< 100 × 10(9)/L) caused by platelet destruction with an increased risk of mucocutaneous bleeding. The diagnosis of ITP depends on clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zahran, Asmaa M., Aly, Sanaa Shaker, Elabd, Ahmed, Mohamad, Ismail Lotfy, Elsayh, Khalid I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155846/ https://www.ncbi.nlm.nih.gov/pubmed/32300398 http://dx.doi.org/10.14740/jh336w

Ejemplares similares

Regulatory T cells in children with recently diagnosed type 1 diabetes
por: Zahran, Asmaa Mohamed, et al.
Publicado: (2012)

Regulatory T-lymphocyte subsets in children with chronic immune thrombocytopenia after high-dose of dexamethasone
por: Elsayh, Khalid Ibrahim, et al.
Publicado: (2022)

Clinical Significance of T-Cell Immunoglobulin Mucin 3 Expression on Peripheral Blood Mononuclear Cells in Pediatric Acute Immune Thrombocytopenia
por: Zahran, Asmaa M., et al.
Publicado: (2017)

Contributions of T Lymphocyte Abnormalities to Therapeutic Outcomes in Newly Diagnosed Patients with Immune Thrombocytopenia
por: Zhao, Zhenhua, et al.
Publicado: (2015)

CD56 and CD11b Positivity with Low Smac/DIABLO Expression as Predictors of Chemoresistance in Acute Myeloid Leukaemia: Flow Cytometric Analysis
por: Ibrahim, Abeer, et al.
Publicado: (2018)

Platelet Activation and Platelet–Leukocyte Aggregates in Type I Diabetes Mellitus
por: Zahran, Asmaa M., et al.
Publicado: (2018)

Upregulation of CD146 in Pediatric B-Cell Acute Lymphocytic Leukemia and Its Implications on Treatment Outcomes
por: Zahran, Asmaa M., et al.
Publicado: (2020)

Effects of royal jelly supplementation on regulatory T cells in children with SLE
por: Zahran, Asmaa M., et al.
Publicado: (2016)

Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia
por: Grainger, John D., et al.
Publicado: (2021)

Adolescents and young adults with newly diagnosed primary immune thrombocytopenia
por: Schifferli, Alexandra, et al.
Publicado: (2023)

Platelet to Lymphocyte Ratio and Glucocorticoid Resistance in Newly Diagnosed Primary Immune Thrombocytopenia: A Retrospective Cohort Study
por: Wang, Lin-Hui, et al.
Publicado: (2019)

A case of newly diagnosed immune thrombocytopenia in the COVID-19 era
por: Clerici, Bianca, et al.
Publicado: (2020)

Could the Crosstalk Between Myeloid-Derived-Suppressor Cells and Regulatory T Cells Have a Role in Beta-Thalassemia?
por: Zahran, Asmaa M., et al.
Publicado: (2023)

Down-regulation of Regulatory T-cells in Children With Gaucher Disease Under Enzyme Replacement Therapy
por: Zahran, Asmaa M., et al.
Publicado: (2019)

Hypovitaminosis D Influences the Clinical Presentation of Immune Thrombocytopenia in Children with Newly Diagnosed Disease
por: Petrovic, Davor, et al.
Publicado: (2019)

Doppler ultrasound screening in patients with newly diagnosed heparin-induced thrombocytopenia
por: Harris, Elyse I., et al.
Publicado: (2021)

Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration
por: Idogun, Precious O, et al.
Publicado: (2021)

Delineation of T cell subsets in chronic rhinosinusitis with nasal polyps
por: Zahran, Asmaa M., et al.
Publicado: (2022)

Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker
por: Zahran, Asmaa M., et al.
Publicado: (2021)

Corrigendum: Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker
por: Zahran, Asmaa M., et al.
Publicado: (2022)

Increase in polymorphonuclear myeloid-derived suppressor cells and regulatory T-cells in children with B-cell acute lymphoblastic leukemia
por: Zahran, Asmaa M., et al.
Publicado: (2021)

ESPED survey on newly diagnosed immune thrombocytopenia in childhood: how much treatment do we give?
por: von Lukowicz, Hannah, et al.
Publicado: (2021)

Comparison of up-front treatments for newly diagnosed immune thrombocytopenia -a systematic review and network meta-analysis
por: Arai, Yasuyuki, et al.
Publicado: (2018)

The Efficacy of High-Dose Dexamethasone vs. Other Treatments for Newly Diagnosed Immune Thrombocytopenia: A Meta-Analysis
por: Xiao, Qirong, et al.
Publicado: (2021)

Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice
por: Snell Taylor, Sara J., et al.
Publicado: (2021)

Clinical Epidemiology, Treatment Outcome and Mortality Rate of Newly Diagnosed Immune Thrombocytopenia in Adult Multicentre Study in Malaysia
por: Hamzah, Roszymah, et al.
Publicado: (2022)

Association between P-Selectin Autoantibody Positive and Response to Steroid Treatment in Newly Diagnosed Immune Thrombocytopenia Patients
por: Wang, Li, et al.
Publicado: (2022)

Survival outcomes of CD34(+)CD38(−)LSCs and their expression of CD123 in adult AML patients
por: Zahran, Asmaa M., et al.
Publicado: (2018)

Short-term dose-escalated romiplostim for preparing an adult patient with persistent newly diagnosed primary immune thrombocytopenia for splenectomy
por: Murray, Nigel P., et al.
Publicado: (2020)

Efficacy and safety of treatments in newly diagnosed adult primary immune thrombocytopenia: A systematic review and network meta-analysis
por: Wang, Yun, et al.
Publicado: (2022)

Low-dose intravenous immunoglobulin for children with newly diagnosed immune thrombocytopenia: protocol of a systematic review and meta-analysis
por: Ren, Xiangge, et al.
Publicado: (2023)

Effect of Hydroxyurea Treatment on the Inflammatory Markers Among Children With Sickle Cell Disease
por: Zahran, Asmaa M., et al.
Publicado: (2020)

Thrombocytopenia is not mandatory to diagnose haemolytic and uremic syndrome
por: Sallée, Marion, et al.
Publicado: (2013)

Soluble CD40 Ligand Levels in Children with Newly Diagnosed Graves’ Disease
por: Metwalley, Kotb Abbass, et al.
Publicado: (2020)

Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Can Boost Immune Disruption
por: Zahran, Asmaa M, et al.
Publicado: (2021)

Imbalance of T Lymphocyte Subsets in Adult Immune Thrombocytopenia
por: Lin, Xiuxiu, et al.
Publicado: (2021)

Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma
por: Landgren, Ola, et al.
Publicado: (2019)

The prognostic impact of lymphocyte subsets in newly diagnosed acute myeloid leukemia
por: Park, Yumi, et al.
Publicado: (2018)

Prevalence and the impact of hypogammaglobulinemia in newly diagnosed chronic lymphocytic lymphoma patients
por: Singh, Namrata, et al.
Publicado: (2020)

Mean platelet volume and response to the first line therapy in newly diagnosed adult immune thrombocytopenia patients: a retrospective study
por: AKKUŞ, Erman, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_82snupu3n9uir0tm8198i473q3